CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,515,027 | -1.6% | 33,378 | +21.7% | 0.00% | 0.0% |
Q2 2023 | $1,539,920 | +15.9% | 27,430 | -6.6% | 0.00% | 0.0% |
Q1 2023 | $1,328,269 | +19.8% | 29,367 | +7.7% | 0.00% | +50.0% |
Q4 2022 | $1,108,322 | -35.5% | 27,265 | +3.7% | 0.00% | -50.0% |
Q3 2022 | $1,717,000 | +35.9% | 26,280 | +26.5% | 0.00% | +33.3% |
Q2 2022 | $1,263,000 | -17.3% | 20,782 | -14.7% | 0.00% | 0.0% |
Q1 2022 | $1,528,000 | -46.2% | 24,350 | -35.0% | 0.00% | -40.0% |
Q4 2021 | $2,841,000 | -13.9% | 37,490 | +27.2% | 0.01% | -28.6% |
Q3 2021 | $3,299,000 | +2.4% | 29,472 | +48.0% | 0.01% | 0.0% |
Q2 2021 | $3,223,000 | -4.6% | 19,908 | -28.2% | 0.01% | -12.5% |
Q1 2021 | $3,380,000 | +1.7% | 27,742 | +27.9% | 0.01% | 0.0% |
Q4 2020 | $3,322,000 | +160.1% | 21,698 | +42.1% | 0.01% | +100.0% |
Q3 2020 | $1,277,000 | +36.7% | 15,267 | +20.1% | 0.00% | +33.3% |
Q2 2020 | $934,000 | +103.5% | 12,707 | +17.4% | 0.00% | +50.0% |
Q1 2020 | $459,000 | -30.1% | 10,824 | +0.3% | 0.00% | 0.0% |
Q4 2019 | $657,000 | +75.7% | 10,787 | +18.4% | 0.00% | +100.0% |
Q3 2019 | $374,000 | -6.5% | 9,114 | +7.2% | 0.00% | -50.0% |
Q2 2019 | $400,000 | +51.5% | 8,503 | +14.9% | 0.00% | +100.0% |
Q1 2019 | $264,000 | +22.8% | 7,401 | -1.5% | 0.00% | 0.0% |
Q4 2018 | $215,000 | -62.7% | 7,511 | -42.3% | 0.00% | -66.7% |
Q3 2018 | $577,000 | -24.6% | 13,014 | 0.0% | 0.00% | -25.0% |
Q2 2018 | $765,000 | – | 13,014 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |